Social Determinants of Health in Glioblastoma Population
NCT03900689 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-12-14
Summary
The overall aim of this study is to prospectively characterize social health disparities in a cross-sectional cohort of glioma patients with attention to exploring and thematically categorizing the patient-specific and community-level factors. This will be conducted in two parts.
Conditions
- Glioma
- Astrocytoma
- Oligodendroglioma
- Ependymoma
- Ganglioglioma
- Pleomorphic Xanthoastrocytoma
Interventions
- OTHER
-
Part 1 Survey Group
At the first study visit, participants will answer a series of survey questions about their neighborhoods, educational levels, social activities, access to transportation and food, healthcare management and where participants find social and spiritual support. General information such as age, ethnicity and address will also be collected.
- OTHER
-
Part 2 Focus Group
If participants from Part 1 agree to be contacted for Part 2, participants will be included in a focus group to explore unexpected findings and further investigate social determinants identified in Part 1.
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Roy E. Strowd, III, MD · Wake Forest University Health Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-22
- Primary Completion
- 2022-03-27
- Completion
- 2022-03-27
Countries
- United States
Study Locations
More Related Trials
-
Bioenergetic Profiling and Cognition in GBM Patients
NCT03939858 ·Status: TERMINATED
-
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
NCT01135875 ·Status: COMPLETED
-
Glioma Microenvironment an Exploratory Study
NCT03189420 ·Status: ACTIVE_NOT_RECRUITING
-
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery
NCT01417507 ·Status: COMPLETED
-
Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
NCT01305122 ·Status: TERMINATED ·Phase: NA
-
Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields
NCT03501134 ·Status: COMPLETED
-
Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Population
NCT05486923 ·Status: COMPLETED
-
Evaluation of Factors in Human Brain Tumors
NCT00001171 ·Status: COMPLETED
-
Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
NCT03439332 ·Status: COMPLETED
-
Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
NCT03903419 ·Status: UNKNOWN ·Phase: NA
-
Determination of Immune Phenotype in Glioblastoma Patients
NCT02751138 ·Status: COMPLETED
-
A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas).
NCT05331521 ·Status: RECRUITING ·Phase: PHASE3
-
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs
NCT06203496 ·Status: RECRUITING
-
Whole-Brain Tumor Burden Metrics with Inflammatory and Molecular Markers to Predict Postoperative Neurocognitive Decline in Glioma
NCT06885333 ·Status: COMPLETED
-
Improving Survivorship and Health-related Quality of Life in Patients With Primary Brain Tumours
NCT06014398 ·Status: UNKNOWN ·Phase: NA
-
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics
NCT02047058 ·Status: UNKNOWN
-
CSF Proteomic Characterization of Glioblastomas
NCT06845020 ·Status: NOT_YET_RECRUITING
-
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
NCT05692635 ·Status: RECRUITING ·Phase: PHASE2
-
The Predictive Value of MRI for Adult-type Diffuse Gliomas
NCT06572592 ·Status: NOT_YET_RECRUITING
-
Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
NCT04553757 ·Status: ACTIVE_NOT_RECRUITING
-
Using the Epitranscriptome to Diagnose and Treat Gliomas
NCT06575452 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
NCT03287063 ·Status: TERMINATED
-
Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma
NCT05941234 ·Status: RECRUITING ·Phase: NA
-
Treatment Decision-making in Patients With Recurrent High-grade Glioma
NCT04013828 ·Status: COMPLETED
-
Natural History of Patients With Brain and Spinal Cord Tumors
NCT00009035 ·Status: COMPLETED